肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
临床试验招募
登录/注册
VIP特权
广告
广告加载中...

文章:

P00年至2021年波兰女性生殖器官恶性肿瘤死亡率趋势——一项基于人群的研究

Trends in Mortality Due to Malignant Neoplasms of Female Genital Organs in Poland in the Period 2000–2021—A Population-Based Study

原文发布日期:3 March 2024

DOI: 10.3390/cancers16051038

类型: Article

开放获取: 是

 

英文摘要:

The aim of this study is to assess mortality trends due to malignant neoplasms of female genital organs (MNFGOs) in Poland between 2000 and 2021. For the purpose of the study, the authors used data on all deaths of Polish female inhabitants due to MNFGO between 2000 and 2021, obtained from the Statistics Poland database. The standardised death rates (SDR), potential years of life lost (PYLL), annual percentage change (APC) and average annual percentage change (AAPC) were calculated. Between the years 2000 and 2021, 138,000 women died due to MNFGOs in Poland. Of this number, 54,975 (39.8%) deaths were caused by ovarian cancer, 37,487 (27.2%) by cervix uteri cancer, and 26,231 (19.0%) by corpus uteri cancer. A decrease in mortality due to cervix uteri cancer (APC = −2.4%,p< 0.05) was the most favourable change that occurred in the period 2000–2021, while the least favourable change was an increase in mortality due to corpus uteri cancer for the period 2005–2019 (APC = 5.0%,p< 0.05). SDRs due to ovarian cancer showed a decreasing trend between 2007 and 2021 (APC = −0.5%,p< 0.05). The standardised PYLL index due to cervical cancer was 167.7 per 100,000 women in 2000 and decreased to 75.0 in 2021 (AAPC = −3.7,p< 0.05). The number of lost years of life due to ovarian cancer decreased from 143.8 in 2000 to 109.5 in 2021 (AAPC = −1.3,p< 0.05). High values of death rates due to MNFGO in Poland, compared to other European countries, show that there is a need to promote preventive programmes and continue to monitor changes in mortality.

 

摘要翻译: 

本研究旨在评估2000年至2021年间波兰女性生殖器官恶性肿瘤(MNFGOs)的死亡率趋势。研究采用波兰统计局数据库中2000年至2021年波兰女性居民因MNFGO死亡的全部数据,计算了标准化死亡率(SDR)、潜在生命损失年数(PYLL)、年度百分比变化率(APC)及平均年度百分比变化率(AAPC)。2000年至2021年间,波兰共有13.8万名女性死于MNFGOs,其中卵巢癌导致54,975例死亡(占39.8%),宫颈癌导致37,487例死亡(占27.2%),子宫体癌导致26,231例死亡(占19.0%)。2000-2021年间最显著的变化是宫颈癌死亡率下降(APC = −2.4%, p<0.05),而2005-2019年间最不利的变化是子宫体癌死亡率上升(APC = 5.0%, p<0.05)。卵巢癌的标准化死亡率在2007-2021年间呈下降趋势(APC = −0.5%, p<0.05)。宫颈癌标准化PYLL指数从2000年的每10万女性167.7降至2021年的75.0(AAPC = −3.7, p<0.05);卵巢癌导致的寿命损失年数从2000年的143.8降至2021年的109.5(AAPC = −1.3, p<0.05)。与其他欧洲国家相比,波兰MNFGO死亡率仍处于较高水平,这表明有必要加强预防项目的推广并持续监测死亡率变化。

 

原文链接:

Trends in Mortality Due to Malignant Neoplasms of Female Genital Organs in Poland in the Period 2000–2021—A Population-Based Study

广告
广告加载中...